Fertility care among people with primary ciliary dyskinesia

Study design and ethics

We obtained study data from a cross-sectional questionnaire about fertility nested within the COVID-PCD study. COVID-PCD is an international participatory cohort study that collects information directly from people with PCD (clinicaltrials.gov: NCT04602481). A detailed study protocol has been published ²². In brief, the COVID-PCD study was set up in 2020 at the University of Bern, Switzerland in collaboration with international PCD patient support groups to follow people with PCD through the pandemic and answer other PCD-related research questions. The COVID-PCD study enrolls participants of any age with PCD from all over the world with suspected or confirmed PCD diagnoses. The study is online, anonymous, and longitudinal. Questionnaires are available in five languages (English, French, German, Italian, and Spanish).

The cantonal ethics committee of Bern approved the study (study ID: 2020-00830). We obtained informed consent either from participants or parents of participants younger than age 14. We report according to strengthening the reporting of observational studies in epidemiology (STROBE) recommendations ²³.

Study procedures

Participants registered via the study website (www.covid19pcd.ispm.ch) and received a baseline questionnaire, then weekly follow-up questionnaires. We sent a fertility questionnaire by email on July 12, 2022 to all participants enrolled in the COVID-PCD study. We sent up to three reminders if participants did not yet complete the questionnaire. We collected responses until March 8, 2023. All data was entered directly in a web-based database using the Research Electronic Data Capture (REDCap) platform ²⁴ hosted by the Swiss medical registries and data linkage center (SwissRDL) at the University of Bern.

Fertility questionnaire

We developed the fertility questionnaire based on existing literature, and we discussed it with fertility specialists and patient representatives from PCD support groups. We include questions and answer categories in Supplementary Table S1. We developed separate questionnaires for adults older than 18 years, adolescents ages 14–17 years, and parents of children with PCD younger than 14 years. Native speaking members from patient support groups or our research team translated questionnaires; two research team members independently checked translations.

Information on fertility care characteristics

In the adult questionnaire, we asked participants if ever referred to fertility specialists; if so, at what age and who provided referrals. We calculated time until fertility specialist visit as the difference between age at PCD diagnosis (or age 18 for people diagnosed during childhood) and age at fertility specialist visit. We excluded adults who were diagnosed with PCD only after fertility specialist visits or with unreported ages at PCD diagnosis or at fertility specialist visit.

We asked all participants (adults, adolescents, and parents) their opinions about the need for fertility care, their fertility information seeking behaviors, and sources of fertility information they used. Among participants who previously talked with healthcare professional about fertility, we asked about what topics were discussed and whether they were satisfied with fertility information they received. We asked participants who reported they were either partly satisfied or unsatisfied with provided fertility information to pinpoint information gaps.

We studied how fertility care from fertility specialists differed by age and country. For adults, age at survey, age at diagnosis, and age at fertility specialist visit were categorized as either 18–30 years, 31–45 years, or older than 45 years. We chose age groups according to physiological female fertility changes with peak reproductive years between late teens and late 20s; declining fertility starting by age 30 and by age 45, fertility declining so much pregnancy without medical assistance is unlikely for most females ²⁵. For simplicity, we used the same age groups for males. We categorized country of residence. We combined Canada and the United States as North America because their PCD care is organized in a network. We included England, Northern Ireland, Scotland, and Wales as the United Kingdom. We grouped countries with fewer than 25 participants into either “other European countries” or “other non-European countries” (Supplementary Table S2).

Study population

In total, 384 of 723 COVID-PCD participants (response rate 53%) completed the fertility questionnaire (Supplementary Table S3). Of these, 266 were adults (69%) with a median age of 44 years [interquartile range (IQR) 33–54]; 16 adolescents (4%), and 102 parents of children with PCD (27%). Two-thirds of adult participants were female (181; 68%). Most participants were from North America (71; 18%), the United Kingdom (66; 17%), and Germany (62; 16%). Compared with non- participants, people who completed the fertility questionnaire were older and more often living in Germany, Switzerland, Australia, and other European countries (Supplementary Table S3).

Fertility care among adults

Half of adult participants (128; 48%) reported receiving fertility care from fertility specialists before completing the survey (Table 1) with a higher proportion of males (47; 55%) than females (81; 45%). The median age at fertility specialist visit was 30 years (IQR 27–33). Only 15 (12%) participants were referred by their PCD physicians, while most participants either reported referrals by non-PCD physicians (46; 36%) or organized appointments themselves (43; 34%) (Table 1). The median time between PCD diagnosis (or age 18 for people diagnosed during childhood) and fertility specialist visit was 10 years, and higher among females (11 years, IQR 7–13) than males (7.5 years, IQR 0–14) (p-value 0.06).

Adults who received fertility care from fertility specialists were less often female [odds ratio (OR) 0.4, 95% confidence interval (CI) 0.2–0.8], more often reported prior pregnancy attempts (OR 9.1, 95% CI 3.8–23.6) and fertility as an important issue (OR 5.9, 95% CI 2.6–14.6) (Table 2). The proportion of people who reported fertility care from fertility specialists differed between countries with the highest in France (11; 69%) and lowest in Italy (7; 35%).

Most participants (370; 96%) felt people with PCD should be referred for fertility care by fertility specialists (Table 3), yet opinions about the timing of fertility care differed. More than one-third (144; 38%) reported everyone should be referred; many (102; 27%) thought only people who want children should be referred; some (78; 20%) felt only adults and few (37; 10%) reported only people with unsuccessful pregnancy attempts should be referred.

Fertility information among all participants

Most participants (277; 72%) searched for information about fertility (Table 3). They mostly searched multidisciplinary PCD network websites (119; 43%) or scientific articles (92; 33%). Around half (203; 53%) of all participants talked about fertility with healthcare professionals involved in their PCD care prior to the study, with adult females (108; 60%) and adult males (61; 72%) more often than parents of children (32; 31%) and adolescents (2; 13%) with PCD (Table 3). Participants reported most healthcare professionals mentioned people with PCD may have problems with fertility (females: 97; 90%, males: 53; 87%, parents: 30; 94%) (Figure 1). More than half of adult participants received information about the possibility of fertility treatments (females: 67; 62%, males: 33; 54%) and one-quarter (females: 31; 29%, males: 16; 26%) were informed about fertility awareness factors other than PCD influencing fertility, such as advanced age or lifestyle factors. Overall, half of participants (111; 56%) were satisfied with information from healthcare professionals, ranging from fewer than half of females (49; 45%) to three-quarters of males (43; 72%) (Figure 2). Participants who reported dissatisfaction with fertility information noted information gaps, such as detailed information about effects from PCD on fertility (18; 20%), effects on female fertility specifically (8; 9%) or information and advice on fertility treatments (9; 10%). They reported dissatisfaction with physician knowledge about PCD and fertility (16; 18%). Eight participants reported fertility was not yet relevant because the person diagnosed with PCD was young; and five reported long ago PCD-fertility discussions with little known about PCD at the time of the conversation (Table 4).

• Download figure
• Open in new tab

Figure 1:

Topics covered in fertility discussions with the healthcare professional among females (n = 108), males (n = 60) and parents of children with PCD (n = 32).

• Download figure
• Open in new tab

Figure 2:

Satisfaction with information provided by fertility specialists among females (n = 108), males (n = 60), and parents of children with PCD (n = 32) (COVID-PCD study).

Discussion Summary of findings

In the first study on fertility care among people with PCD, we showed only 48% of adults with PCD reported ever visiting fertility specialists with a median delay of 10 years since diagnosis (or age 18 for people diagnosed during childhood). Only 12% were referred to fertility specialists by their PCD physician. Among participants with PCD who spoke with healthcare professional about fertility, only 56% reported satisfaction with provided information. They expressed needs for more comprehensive fertility information, such as detailed information about effects from PCD on fertility.

Strengths and weaknesses

Using data from the largest study with patient-reported data in PCD, we collected information about fertility care and opinions from people with PCD. Above all, our results represent relevance for people with PCD. Since we conducted our study online and anonymously, we involved people normally with limited involvement in research from many countries around the world.

Our study also has limitations. People who talked with healthcare professionals about fertility long ago possibly found it difficult to recall conversation details, which could lead to recall bias. However, we did not ask detailed questions about fertility discussions; instead, we focused on general aspects and opinions. Therefore, we expected respondents to remember the main points discussed. Fertility is a sensitive topic and people with negative fertility care experiences possibly participate more as an opportunity to make themselves heard, which could lead to selection bias.

Comparison with other studies

To our knowledge, no other study investigated fertility care among people with PCD. Review papers on managing PCD suggest including fertility topics in routine PCD care ^{10, 15}. The PCD Foundation recommends including reproductive medicine “as clinically needed” ⁹; Werner et al. note “infertility is managed with adequate reproductive techniques” ¹⁴; and Lucas et al. suggest integrating fertility care at transition into adult care ¹³. For male infertility, two reviews promote including fertility care during the transition from pediatric to adult care ^27,3. However, none explicitly counsel how and when fertility care should be included; how it should be organized; and what topics should be addressed ⁷. In CF research, recent reproductive health reviews address some of these questions and propose management strategies for healthcare professionals ^{21, 28–31}. However, data on fertility care implementation show reproductive health needs are not proactively addressed among people with CF ³². Adults and adolescents with CF report inadequate communication on the topic from CF care providers ^{17, 18} and delayed introduction of reproductive health education ¹⁶. Only 30% of parents of children with CF were satisfied with their current knowledge of reproductive health ²⁰. Results from our study confirm people with PCD face similar challenges in terms of fertility care and highlight important gaps in PCD care and existing recommendations.

Interpretation of results

Young adults with PCD are not referred to fertility specialists as part of routine PCD care. Most seem only to be referred when experiencing fertility problems, and usually at their own request. Females are referred later than males, although an early visit would be even more important for them since their fertility declines earlier. This suggests fertility care is not satisfactorily integrated in routine PCD care and potential fertility problems are not proactively addressed before becoming relevant to people with PCD. Only one-quarter of participants were informed by healthcare professionals about other fertility awareness factors, such as age, influencing fertility; only half of participants were informed about the possibility of fertility treatments. Our results also suggest great dissatisfaction among people with PCD regarding their fertility care. Most participants expressed a need for more comprehensive information about fertility for people with PCD. This also reflects the general lack of knowledge regarding fertility issues among people with PCD—especially in females—and indicates a need for further research. Until this knowledge gap is filled, fertility care will have limitations.

PCD physicians may not recognize the need to address fertility as it is out of their area of expertise. Nevertheless, it is likely beneficial for PCD physicians to openly discuss potential fertility issues. Already at diagnosis, PCD physicians can provide information about potential impact from PCD on fertility and—no later than the transition to adult care—offer information about fertility awareness, such as age or timing of sexual intercourse. By integrating fertility care, physicians could mention ways to increase chances of pregnancy through fertility treatments and interventions, offer further fertility information, and organize referrals to fertility specialists if needed.